Samuele Cortese

Aug 5, 2024 | jamanetwork.com | Andres Roman-Urrestarazu |Robin van Kessel |Samuele Cortese |Jae Il Shin

Testing the Concerns Regarding the Global Burden of Disease—Reply In Reply In a recent response to our Viewpoint, Cortese et al support our critique of the methodologies used in the Global Burden of Disease (GBD) studies, specifically commenting on Cortese and colleagues’ work on attention-deficit/hyperactivity disorder (ADHD).1 Articles using GBD data have been extensively published with varying impact in the field of child and adolescent mental health and include previous work on autism by...

Aug 5, 2024 | jamanetwork.com | Samuele Cortese |Jae Il Shin |Yonsei College |Marco Solmi

Testing the Concerns Regarding the Global Burden of Disease To the Editor Roman-Urrestarazu and van Kessel1 expressed concerns regarding the accuracy of the incidence, prevalence, and burden of attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) in the Global Burden of Disease (GBD) study.

Aug 5, 2024 | tandfonline.com | Samuele Cortese |David Goodman |Stephen V. Faraone

KEYWORDS: ADHDAttention Deficit Hyperactivity DisorderOlder adultsCognitive declineGeriatrics 1. IntroductionAttention deficit hyperactivity disorder (ADHD) is a neurodevelopmental condition characterized by inappropriate levels of inattention, hyperactivity, and impulsivity, which manifest in various environments [Citation1]. Longitudinal studies show that 60% to 90% of children with ADHD continue to exhibit symptoms and impairments into adulthood [Citation2,Citation3].

Nov 22, 2023 | jamanetwork.com | Samuele Cortese

Long-Term Cardiovascular Effects of Medications for Attention-Deficit/Hyperactivity Disorder—Balancing Benefits and Risks of Treatment ADHD Medications and Long-Term Risk of Cardiovascular Diseases Le Zhang, PhD; Lin Li, PhD; Pontus Andell, MD, PhD; Miguel Garcia-Argibay, PhD; Patrick D. Quinn, PhD; Brian M.

Aug 7, 2023 | tandfonline.com | Valeria Parlatini |Samuele Cortese

ABSTRACTIntroduction Neurological/neuropsychiatric symptoms are commonly reported by children/young people with long COVID, especially headache, fatigue, cognitive deficits, anosmia and ageusia, dizziness, mood symptoms, and sleep problems.